throbber
HYALURONAN
`Volume 1 - Chemical, Biochemical and Biological Aspects
`
`Editors:
`JOHN F. KENNEDY BSe, PhD, OSe, EurChem CChem FRSc, CBiol FIBiol, FCIWEM, FCMI, FIFST
`Director of Birmingham Carbohydrate and Protein Technology Group,
`SchoolofChemical Sciences,The University ofBinningham, BirminghamB15 2IT, England,UK,
`Director of Chembiotech Ltd,
`University of Birmingham Research Park, Birmingham B15 2SQ, England, UK,
`Director of Inovamed Ltd,
`Chembiotech Laboratories, University of Birmingham Research Park, Vincent Drive,
`Birmingham B15 2SQ, England, UK, and
`Professor of Applied Chemistry,
`The North East Wales Institute of Higher Education, Plas Coch, Mold Road, Wrexham, Clwyd,
`LUI 2AW, Wales, UK
`
`GLYN O. PHILLIPS BSe, PhD, OSe, HODOSe, HODLIB, CChem FRSC
`Chairman of Research Transfer Ltd,
`Newtech Innovation Centre,
`Professorial Fellow,
`The North East Wales Institute of Higher Education, Plas Coch, Mold Road, Wrexham, Clwyd,
`LUI 2AW, Wales, UK, and
`Professor of Chemistry,
`The University of Salford, England, UK
`
`PETER A. WILLIAMS BSe, PhD, CChem FRSC
`Director of the Centre for Water Soluble Polymers,
`The North East Wales Institute of Higher Education, Plas Coch, Mold Road, Wrexham, Clwyd,
`LUI 2AW, Wales, UK,
`Director of the Centre for Advanced and Renewable Materials at
`Institute and University of Wales, Bangor,
`The North East Wales Institute of Higher Education, P1as Coch, Mold Road, Wrexham, Clwyd,
`LUI 2AW, Wales, UK
`Professor of Polymer and Colloid Chemistry,
`The North East Wales Institute of Higher Education, Plas Coch, Mold Road, Wrexham, Clwyd,
`. LL11 2AW, Wales, UK
`
`the North East Wales
`
`Guest Editor:
`VINCE C. HASCALL PhD
`Co-Direetor of the Orthopaedic Surgery Musculoskeletal Research Center,
`Department of Biomedical Engineering ND-20, Lerner Research Institute. Cleveland Clinic
`Foundation, Cleveland, Ohio 44195, USA
`Adjunct Professor
`Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio 44106, USA
`Adjunct Professor
`Department of Biochemistry, Rush Presbyterian S1. Lukes Medical Center, Chicago, Illinois,
`60612 USA
`
`WOODHEAD PUBLISHING LIMITED
`
`ALL 2018
`PROLLENIUM V. ALLERGAN
`IPR2019-01505 et al.
`
`

`

`Published by Woodhead Publishing Ltd, Abington Hall, Abington,
`Cambridge CB I 6AH, England
`www.woodhead-publishing.com
`
`First published 2002
`
`© 2002, Woodhead Publishing Ltd
`The authors have asserted their moral rights
`
`Conditions of sale
`This book contains information obtained from authentic and highly regarded sources. Reprinted
`material is quoted with permission, and sources are indicated. Reasonable efforts have been
`made to publish reliable data and information, but the authors and the publishers cannot assume
`responsibility for the validity of all materials. Neither the authors nor the publisher, nor anyone
`else associated with this publication, shall be liable for any loss, damage or liability directly or
`indirectly caused or alleged to be caused by this book.
`Neither this book nor any part may be reproduced or transmitted in any form or by any means,
`electronic or mechanical, including photocopying, microfilming and recording, or by any
`information storage or retrieval system, without permission in writing from the publisher.
`The consent of Woodhead Publishing Limited does not extend to copying for general
`distribution, for promotion, for creating new works, or for resale. Specific permission must be
`obtained in writing from Woodhead Publishing Limited for such copying.
`
`Trademark notice: Product or corporate names may be trademarks or registered trademarks, and
`are used only for identification and explanation, without intent to infringe.
`
`British Library Cataloguing in Publication Data
`A catalogue record for this book is available from the British Library.
`
`ISBN I 85573 5709 (2 volume set)
`
`Printed in Great Britain by MFK Group Ltd
`
`

`

`EFFECT OF METAL IONS ON THE RHEOLOGICAL
`FLOW PROFILES OF HYALURONATE SOLUTIONS
`
`Charles J. Knill t, John F. Kennedy t, Yasmin Latif 1& Derek C. Ellwood 2
`
`J Chembiotech Laboratories, Institute a/Research & Development,
`University 0/ Birmingham Research Park, Vincent Drive,
`Edgbaston, Birmingham, Bl5 2SQ, UK.
`
`2 Department a/Microbiology, Medical School, University a/Newcastle,
`Newcastle Upon Tyne, UK
`
`ABSTRACT
`
`The effects of various metal ions on the rheological flow profiles of hyaluronate
`solutions were investigated, by controlled incubation of metal chloride salt solutions
`with sodium hyaluronate (NaHA) solution under ambient conditions. Results from
`application of the Williamson model to the flow profiles of incubated solutions showed
`a progressive decrease in Williamson zero shear viscosity (110) with increasing atomic
`number / atomic mass of the metal ion, which, with the exception of data for u', could
`be related to a power equation (y = cxb
`) . Such reductions in viscosity were not a result
`of hydrolysis (determined by GPC), but may be due to diffusing ions disrupting
`hydrogen bonding and shielding electrostatic repulsions between carboxylate groups.
`
`INTRODUCTION
`
`Hyaluronan is a biocompatible / biodegradable, linear, water-soluble, ionic polymer
`composed of repeating (1-H) linked disaccharide units consisting of ~-D-GlcpA and
`~-D-GlcpNAc, linked together by (l~3) glycosidic bonds 1.
`It has a high molecular
`weight (around 105_107 Da), depending on source, giving a DP range of - 250-25000 2.
`It is found in all vertebrates, being present in almost every tissue as a component of the
`extracellular matrix and is distributed throughout the mammalian body, especially in
`synovial fluid, loose connective tissue, umbilical cord and the vitreous body of the eye 3.
`The largest amount of hyaluronan (7-8 g per average human, 50 % of the total in the
`body) is in the skin tissues (both the dermis and epidermis) 4. The most commonly
`isolated / utilised (in vitro) forms of hyaluronan are the free acid (hyaluronic acid, HA)
`and its sodium salt (sodium hyaluronate, NaHA).
`In solution the hyaluronan backbone is stiffened by the chemical structure of linked
`disaccharide units,
`internal hydrogen bonds, mutually repelling anionic groups and
`interactions, making it a rigid and highly hydrated molecule.
`It adopts an
`solvent
`expanded random coil structure in physiological solutions, occupying a large domain.
`Small molecules, e.g. water and electrolytes, can freely diffuse through the domain,
`whilst large molecules are partially excluded due to their hydrodynamic size. At low
`concentrations,
`individual chains entangle forming a continuous network, giving
`viscoelastic and pseudoplastic properties, which is unique for a water-soluble polymer
`at low concentration. At higher concentrations entangled networks can be formed,
`which can resist rapid, short duration fluid flow,
`thus exhibiting elastic properties.
`However, short fluid flow of longer duration can partially separate and align molecules,
`allowing movement and thus exhibiting viscous properties 5.
`
`

`

`176
`
`Rheological behaviour of hyaluronan
`
`The viscoelastic properties of hyaluronan solutions are ideal for use as a biological
`shock absorber and lubricant, which is why it is present in synovial fluid, where it
`lubricates the cartilage between joints. The cartilage provides a cushion between the
`bones allowing the joint to move smoothly. However, in an arthritic joint the elasticity /
`viscosity of the joint fluid is reduced, diminishing the shock absorbing and barrier
`properties 6. Highly viscoelastic hyaluronan solutions can be injected into joints
`(viscosupplementation) in order to restore the rheological environment of the joint and
`thus improve joint function. This is used in osteoarthritic joints to provide instant
`protection and shock absorption, thus decreasing pain associated with mobility.
`The aim of this investigation was to see how the interaction of hyaluronan with a
`range of metal ions (of differing ionic size, valency, etc.) affected the rheological flow
`characterisitics (especially the zero shear viscosity, 110) and molecular weight profile.
`This is of particular interest with respect to localised in vivo applications of hyaluronan,
`since there are numerous metal ions in the body which could interact with administered
`hyaluronan resulting in significant changes in desired physical properties.
`
`MATERIALS & METHODS
`
`Preparation of boiled, nitrogen flushed, deionised water
`
`Deionised water was boiled (~ 5 minutes, under vacuum) to remove dissolved air,
`cooled to ambient temperature, and flushed with nitrogen (- 15 minutes) to displace any
`residual air, and prevent air redissolving. The resultant boiled, nitrogen flushed,
`deionised water was refridgerated (4°C) until required, and was used for the preparation
`of all subsequent solutions (the NaHA and metal salt solutions detailed below).
`Boiling / nitrogen flushing was used to exclude dissolved oxygen from the water to try
`and minimise any oxidative hyaluronan degradation effects.
`
`Preparation of sodium hyaluronate solution
`
`fermentation using
`Sodium hyaluronate (NaHA, 6 g, produced by microbial
`Streptococcus equi) was dispersed in boiled, nitrogen flushed, deionised water (600 mL)
`in a conical flask (1 L), and the flask headspace was flushed with nitrogen. The flask
`was stoppered and the NaHA allowed to dissolve slowly over a period of- 48 hours (at
`4°C), with ocasional gentle agitation / swirling to assist solubilisation, resulting in a
`viscous, homogenous NaHA solution (1 % w/v). Care was taken to avoid the use of any
`metal equipment
`in the production of the hyaluronate solution (especially items
`containing iron / stainless steel), to minimise potential degradatory effects.
`
`Preparation of metal ion solutions
`
`Metal chloride salt solutions (0.25 M) were prepared by dissolving the necessary
`amounts of anhydrous lithium chloride (LiCI, M, 42.39), sodium chloride (NaCl,
`M, 58.44), potassium chloride (KCI, M, 74.55), anhydrous calcium cloride (CaCh,
`Mw 111.0), manganese (II) chloride tetrahydrate (MnCh.4H20, Mw 197.9), cobalt (II)
`chloride hexahydrate (CoCh.6H20, M, 237.9), and cerium (ill) chloride heptahydrate
`in
`(CeCh.7H20, Mw 372.6), in boiled, nitrogen flushed, deionised water (50 mL)
`volumetric flasks (50 mL). All salt solutions were filtered (using 0.45 11m pore size,
`25 mm diameter Titan nylon membrane filters), and flushed with nitrogen (to remove
`any dissolved air / oxygen), before use in hyaluronate incubation experiments.
`
`

`

`Effect of metal ions on now profiles
`
`177
`
`Incubation of hyaluronate with metal ions
`
`Aliquots of NaHA solution (1 % w/v, 5 mL) were transferred into individual
`headspace vials (20 mL, Merck). Aliquots of the metal chloride salt solutions detailed
`above (0.25 M, 5 mL) were transferred into the individual headspace vials containing
`the NaHA solution (in duplicate) to give overall concentrations of 0.5 % w/v NaHA and
`0.125 M metal ions. The pipette tip used for individual NaHA solution dispensing was
`also utilised for subsequent metal ion solution dispensing, so that the latter ensured any
`residual NaHA was washed out ofthe pipette tip. Duplicate controls were also prepared
`using boiled, nitrogen flushed, deionised water aliquots (5 mL). The resultant solutions
`were flushed with nitrogen (to remove any dissolved air / oxygen, which also facilitated
`mixing), and the vials sealed with butyVPTFE lined (3.0 mm) plain aluminium crimp
`caps (20 mm diameter, Merck). The solutions were incubated at ambient temperature,
`and the rheological flow profiles determined exactly 1 hour after metal ion solution
`addition (as detailed below).
`[This incubation test procedure had been previously
`validated by performing replicate rheological analyses on test solutions (NaHA and
`metal salts), which resulted in Williamson infinite shear viscosity (110) values with %
`variation values of < 10 %].
`
`Determination of rheological flow profiles
`
`All rheological flow profile measurements were performed using a TA Instruments
`AR 1000 'Rheolyst' controlled stress rheometer, equipped with 'Rheology Solutions'
`software (v. 1.2.2). The software is split into two modules, the 'ARI000' module
`controls the instrument itself and enables the operator to set up experimental procedures
`and perform the actual experiments, whilst the 'Data' module manipulates and presents
`the collected data. Duplicate rheological flow profile measurements were performed
`using the test parameters detailed below. Approximately 5 mL of sample was used for
`each flow test (the remainder being stored at 4 °C until molecular weight determinations
`were performed). The 'Data' module was used to apply the Williamson model to the
`resultant flow profiles (shear rate vs viscosity) in order to determine the Williamson
`zero shear viscosity (110) values. The Williamson model describes the low shear
`viscosity behaviour and is derived from the Cross model when 11 »1100 7.
`
`Geometry:
`Geometry gap:
`Geometry inertia:
`Instrument inertia:
`Temperature:
`Pre-experimental shear stress:
`Test stress range:
`Number ofPoints:
`
`parallel plate (4 em diameter)
`500 urn
`- 1.5 J.lNms2(calibrated before each test)
`-14.2 IlNms2(calibrated daily)
`20°C (controlled by Peltier plate)
`1.768 Pa (for 10 s)
`0.5 - 500 Pa (log ramp)
`3I (max. point time 1 min)
`
`Determination of molecular weight profiles
`
`The molecular weight profiles of incubated solutions (0.5 % w/w NaHA, 0.125 M
`metal salt, & controls) detailed above were determined - 12-24 hours after incubation,
`by GPC analysis using the isocratic HPLC system detailed below.
`
`

`

`178
`
`Rheological behaviour ofhyaluronan
`
`Instrumentation:
`
`GPC Columns:
`
`Eluent:
`
`Flow rate:
`Calibration:
`
`Injection volumes:
`Data collection:
`Data manipulation:
`
`Knauer HPLC pump 64
`Waters 712 WISP autoinjector
`Knauer column oven & control unit (set to 30°C)
`Knauer differential refractometer
`Dionex ill 20 Universal interface (for PC data link)
`Progel™TSK G5000, G4000 & G2500 PW (131J.IIl,
`300 x 7.5 mm ill) columns (& guard) linked in series
`0.05 M phosphate buffer containing 0.25 M NaCl, pH 7.0
`(prepared using 18 Mil UHQ water with helium sparging)
`0.5 mL/minute
`Pullulan standards with Mp values of 853, 380, 186, 100,
`48,23.7, 12.2 & 5.8 kDa (0.1 Ilg/J.J.L in UHQ water)
`200 J.J.L (solutions diluted 1 in 10 with UHQ water)
`Dionex Chromeleon software (v. 6.11)
`PL Caliber Reanalysis software (v. 7.04)
`
`RESULTS & DISCUSSION
`
`Mean flow profiles (of duplicate analyses, shear rate vs viscosity) for incubated
`NaHA / metal ion solutions (and controls) are displayed in Figures I & 2, and show that
`incubation with metal ions results in a reduction in viscosity. GPC analysis showed that
`the control sample (NaHA + water, i.e. no additional metal ions added) had Mp and
`polydispersity (Mw/Mn) values of2.5 x 106 Da and 1.6, respectively. Incubated samples
`had Mp values in the region of 1.9-2.5 x 106 Da and polydispersity values in the region
`of 1.7-2.0, i.e. no significant degradation had taken place.
`The Williamson model was applied to the flow profiles to determine the Williamson
`zero shear viscosities (Tlo) 7. This is the region where increasing shear stress / shear rate
`has little or no effect on viscosity (i.e. Newton's law ofliquid flow is obeyed).
`
`__ control
`
`-.-Na
`__ Li
`
`-+-Mn
`
`1.00
`
`Ui'
`iiie:.
`~ 0.10
`IIIo
`II's
`
`UI
`
`0.01 ~--r"""''''''''",,"",r'I'T''"-'''''''''I""''T""'I"T'''l''I''IT"--'-T"''T...........,-......-r-I'''T'''I,,","
`10
`100
`1000
`10000
`1
`shear rate (1/5)
`Mean flow profiles (shear rate vs viscosity) for NaHA solutions
`incubated with water (control), Na+,u: and Mn2+ ions (all cr salts).
`
`Figure 1.
`
`

`

`Effect of metal ions on now profiles
`
`179
`
`_K
`-.-Ca
`_Co
`_Ce
`
`1.00
`
`'iii'
`rei
`!:!;.
`~ 0.10
`'iii
`ou
`VI.:;
`
`0.01 -l-......-'T""T""r-TT........--r-..,.....,,.....,........or----r--r............,.,.......-or--or-r..,...,.......,
`10
`100
`1000
`10000
`1
`shear rate (1/s)
`Mean flow profiles (shear rate vs viscosity) for NaHA solutions
`incubated with K+, C~+, C02+ and CeJ+ ions (all cr salts).
`
`Figure 2.
`
`The Williamson zero shear viscosities (110) were related to the atomic number and
`atomic mass of the associated metal ions used in the incubation (Figure 3). The data
`
`(with the exception ofLn could be satisfactorily modelled using the power equation
`y = cxb (Figure 3). No obvious correlation could be obtained between the Williamson
`shear viscosity (Tjo) and ionic radii /
`ionic volume of the metal ions used in the
`incubation.
`
`0.6
`
`0.5
`
`0.4
`
`-;
`cO
`2::- 0.3
`0
`!='
`
`0.2
`
`0.1
`
`\
`
`\
`
`\0
`
`\
`
`\
`
`\,
`\.,
`
`.0
`
`\ 0,
`"
`0' ••
`
`•
`
`o
`
`atomic number
`
`atomic mass
`
`y = 4.9571 X.o·
`
`oCr--------......-- .....-----------0 _
`
`7615
`
`0.0 +---.---r---.---.---r-...---r-or---.--..--.......-....-.......-....--.
`o 10
`20 30
`40 50
`60 70
`80 90 100 110 120 130 140 150
`
`Figure 3.
`
`The relationship between the Williamson zero shear viscosity (Tjo) and
`the atomic number / atomic mass of the metal ion used for incubation.
`
`

`

`180
`
`Rheological behaviour of hyaluronan
`
`These results are in agreement with previous published data, where zero shear
`viscosity (110) was found to decrease for the series Na+, K+ and Ca2+, and Na+, Lt and
`It has been suggested that these observed reductions in viscosity are a result of
`K+ 8,9.
`ions diffusing between the hyaluronan chains and shielding electrostatic repulsions
`(between nearby carboxylate groups) and disrupting hydrogen bonding interactions
`between chains 8. This would result in a collapse of expanded stiffened coil structure to
`a more compact structure where chains could slide over each other more easily
`(i.e. flow), thereby leading to a reduction in viscosity.
`
`CONCLUSIONS
`
`As the atomic number / atomic mass of the metal ion increased, a progressive
`Contact with metal
`decrease in Williamson zero shear viscosity (110) was observed.
`ions thus alters the rheological characteristics of hyaluronan, which may in tum
`adversely affect its functional application properties. The body contains an abundance
`of metal ions (especially K+, Na+, Ca2+ and Mg2+), which therefore have the potential to
`alter the viscosity of administered hyaluronan-based materials. The effect of Li+
`seemed to be more pronounced than expected (based solely upon its charge, size, etc),
`which is of particular interest since a considerable number of pharmaceutical products
`contain lithium.
`The effects of a broader range of metal ions of higher valency should be investigated
`(e.g. Al3+, Ti4+ & Sn4+) to see if any further correlations can be made. The effects of
`such metal ions on the viscoelasticity ofhyaluronan materials (using creep & oscillation
`measurements) also merits investigation.
`
`REFERENCES
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`8.
`
`9.
`
`A. Linker & K. Meyer, Production of unsaturated uronides by bacterial hyaluronidases,
`Nature (London), 1954, 174, 1192-1193.
`T. C. Laurent, Structure of hyaluronic acid, In: Chemistry and Molecular Biology of the
`Extracellular Matrix, Vol. 2, E. A. Balazs (ed.), 1970, Academic Press, New York,
`pp.703-732.
`K. Meyer & J. W. Palmer, The polysaccharide of the vitreous humor, J. Bioi. Chem.,
`1934, 107,629-634.
`J. R. E. Fraser & T. C. Laurent, Turnover and metabolism ofhyaluronan, In: The Biology
`ofHyaluronan, Ciba Foundation Symposium 143, D. Evered & J. Whelan (eds.), 1989,
`John Wiley & Sons, Chichester, pp. 41-53.
`R. E. Turner, P. Lin & M. K. Cowman, Self-association of hyaluronate segments in
`aqueous NaCl solution, Arch. Biochem. Biophys., 1988, 265, 484-495.
`M. F. McCarty, A. L. Russel & M. P. Seed, Sulphated glycosaminoglycans and
`glucosamine may synergize in promoting synovial hyaluronic acid synthesis, Med.
`Hypotheses, 2000, 54 (5), 798-802.
`H. A. Barnes, J. F. Hutton & K. Walters, An Introduction to Rheology, Rheology Series
`Vol. 3, 1989, Elsevier, Amsterdam, pp. 16-23.
`Y. Kobayashi, A. Okamoto & K. Nishinari, Viscoelasticity of hyaluronic acid with
`different molecular weights, Biorheology, 1994,11 (3), 235-244.
`K. Ogino, Viscoelastic properties of hyaluronic aqueous solutions, Kobushu Ronbunshu,
`1998, 55 (12), 736-748.
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket